Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
System and method for advertising messages on distributed document processing devices
Breathing mask
Compounds, compositions and use
Wide bandwidth hybrid antenna for combination EAS and RFID label or tag
Machine tool with an electrical generator for passive power generation
Electrical installation arrangement
System for seeking for an optimal configuration of a bi-, tri- or multi-ventricular cardiac resynchronization implanted device
  Randomly Featured Patents
Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
Ball bearing turbocharger balancer
Support device and manufacturing method thereof, stage device, and exposure apparatus
Container base
Linear adjustment operator for pressure control of paint pumps
Concrete wall and forming system therefore
Fluoxetine process from benzoylpropionic acid
Safety razor or the like
Thermal treatment processes for spent hydroprocessing catalyst
Portion of a keyboard